Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MMP-28 (epilysin) is a recently cloned member of the
MMP
(matrix metalloproteinase) family. It is highly expressed in the skin by keratinocytes, the developing and regenerating nervous system and a number of other normal human tissues, as well as a number of carcinomas. The
MMP28
promoter has previously been cloned and characterized identifying a conserved GT-box that binds Sp1/Sp3 (specificity proteins 1 and 3) proteins and is essential for the basal expression of the gene. The present study demonstrates that
MMP28
expression is induced by HDAC (histone deacetylase) inhibitors and that this effect is mediated through the GT-box. Transient transfection assays have shown that the induction of
MMP28
expression by the HDAC inhibitior TSA (trichostatin A) is mediated via Sp1 at the GT-box. Immunoprecipitation experiments have shown that the acetylation of Sp1 and Sp3 is increased by TSA treatment; however, no effect on DNA binding was observed. Histone acetyltransferases such as p300 and P/CAF [p300/CREB (cAMP-response-element-binding protein)-binding protein-associated factor] increased induction of the
MMP28
promoter by Sp1. Knockdown of HDAC1 using siRNA (small interfering RNA) also induces the
MMP28
promoter. Oligonucleotide pulldown identified STRAP (serine/threonine kinase receptor-associated protein) as a further protein recruited to the
MMP28
promoter and acting functionally with Sp1.
...
PMID:MMP28 gene expression is regulated by Sp1 transcription factor acetylation. 2014 49
Members of the
MMP
family function in various processes of innate immunity, particularly in controlling important steps in leukocyte trafficking and activation.
MMP28
(epilysin) is a member of this family of proteinases, and we have found that
MMP28
is expressed by macrophages and regulates their recruitment to the lung. We hypothesized that
MMP28
regulates other key macrophage responses, such as macrophage polarization. Furthermore, we hypothesized that these
MMP28
-dependent changes in macrophage polarization would alter fibrotic responses in the lung. We examined the gene expression changes in WT and Mmp28-/- BMDMs, stimulated with LPS or IL-4/IL-13 to promote M1 and M2 cells, respectively. We also collected macrophages from the lungs of Pseudomonas aeruginosa-exposed WT and Mmp28-/- mice to evaluate changes in macrophage polarization. Lastly, we evaluated the macrophage polarization phenotypes during bleomycin-induced pulmonary fibrosis in WT and Mmp28-/- mice and assessed mice for differences in weight loss and total collagen levels. We found that
MMP28
dampens proinflammatory macrophage function and promots M2 programming. In both in vivo models, we found deficits in M2 polarization in Mmp28-/- mice. In bleomycin-induced lung injury, these changes were associated with reduced fibrosis.
MMP28
is an important regulator of macrophage polarization, promoting M2 function. Loss of
MMP28
results in reduced M2 polarization and protection from bleomycin-induced fibrosis. These findings highlight a novel role for
MMP28
in macrophage biology and pulmonary disease.
...
PMID:MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis. 2779 42